Neuro-pharmaceutical firm MindMed raises funding
Toronto-based MindMed, a neuro-pharmaceutical company for psychedelic-inspired medicines, has secured US$6.2 million in funding. The investors included Bruce Linton, ex-CEO and founder of cannabis company Canopy Growth, Canadian businessman and "Shark Tank" co-host Kevin O'Leary, Compass Pathways and James Bailey, a partner at Bail Capital. In addition to the funding, Linton will join MindMed's board.
2 October 2019•3 mins read
